We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Diversity & Inclusion

Diversity & Inclusion

Fostering belonging for our people, advancing inclusive research and health equity for all patients, and investing in transformative partnerships that strengthen D&I across healthcare, education and within all communities.